TCS reported a 5% growth in Q2 net profit to Rs 11,909 crore, falling short of expectations. Revenue increased 8% YoY. Analysts hold mixed views; JPMorgan and Nuvama maintain ‘Buy’ ratings, while Citi and Investec advise ‘Sell’ due to ongoing client-specific issues.
Wakefit IPO: Check GMP, price band, review, subscription and other details
Wakefit Innovations, known for its mattresses, is launching its IPO with a positive grey market outlook. The company is raising over Rs 1,200 crore. Despite